|
| Gene | RANBP2 |
| UniProt ID | P49792 |
| Mol. Weight | 358 kDa |
| Localization | Nuclear pore complex, cytoplasm |
| Family | Nucleoporin family |
| Diseases | ALS, Acute Necrotizing Encephalopathy |
Ranbp2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
RANBP2 is a massive nucleoporin protein that serves as a critical component of the nuclear pore complex (NPC). It plays essential roles in nucleocytoplasmic transport, protein quality control, and neuronal function.
RANBP2 is one of the largest human proteins at 3224 amino acids. Key structural features include:
- Leucine-rich repeats: Domains involved in protein-protein interactions
- RAN-binding domains: Direct interaction with the GTPase RAN
- Zinc finger domains: Involved in protein folding and interactions
- SUMO E3 ligase domain: Catalytic domain for SUMOylation
- Cyclophilin domain: Possesses peptidyl-prolyl isomerase activity
The protein forms a flexible scaffold that extends into both the cytoplasm and nucleoplasm from the nuclear pore.
RANBP2 is essential for bidirectional transport between nucleus and cytoplasm:
- Importin pathway: Facilitates nuclear import of proteins
- Exportin pathway: Supports nuclear export of mRNA and proteins
- Cargo recognition: Provides docking sites for transport factors
- RAN-GTPase cycle: Coordinates with RAN for directional transport
Beyond transport, RANBP2 functions as:
- Chaperone: Assists in protein folding and prevents aggregation
- SUMO E3 ligase: Catalyzes SUMOylation of target proteins
- Proteostasis regulator: Maintains protein homeostasis
In neurons, RANBP2 has specialized roles:
- Axonal integrity: Supporting cytoskeletal organization
- Synaptic maintenance: Regulating synaptic protein composition
- Neuroprotection: Protecting against stress-induced damage
- Mitochondrial function: Interacting with mitochondrial proteins
RANBP2 dysfunction contributes to ALS through multiple mechanisms:
- Impaired import of nuclear proteins
- Cytoplasmic mislocalization of TDP-43 and FUS
- Nuclear envelope abnormalities
- Loss of chaperone function promotes aggregation
- Inability to clear misfolded proteins
- Enhancement of stress granule formation
- High metabolic demands of motor neurons
- Dependence on efficient nucleocytoplasmic transport
- Accumulation of toxic protein aggregates
RANBP2 mutations cause susceptibility to ANE:
- Triggered by viral infections (influenza, etc.)
- Results in symmetric brain lesions
- Severe neurological deterioration
- Nuclear transport enhancers: Improving nucleocytoplasmic trafficking
- SUMOylation modulators: Targeting RANBP2's enzymatic activity
- Chaperone boosters: Enhancing protein quality control
- Gene therapy: Delivering functional RANBP2
- Asakura H, et al. "RANBP2 mutations and acute necrotizing encephalopathy." Nature Genetics 2009.
- Zhang K, et al. "Nucleocytoplasmic transport disruption in ALS." Nature 2015.
The study of Ranbp2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Asakura H, et al. RANBP2 mutations. Nature Genetics 2009.
- Zhang K, et al. Nuclear transport in ALS. Nature 2015.